Could LVAD patients ditch aspirin? new trial aims to find out
NCT ID NCT07644247
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether patients with a heart pump (LVAD) can safely stop taking aspirin while continuing warfarin. The goal is to reduce bleeding problems without increasing dangerous clots. About 370 participants will be randomly assigned to receive either aspirin or a placebo, and researchers will track strokes, pump clots, and major bleeding for one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- aspirin
- What this could lead to
- If successful, this could simplify medication for LVAD patients by safely removing aspirin, reducing bleeding risks while still preventing clots.
- What could go wrong
- This is a Phase 4 trial, but it's not yet recruiting. Removing aspirin might increase the risk of dangerous clots or strokes, and results may not apply to other LVAD devices.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal zaps could reboot breathing after brain injury
- Can brain scans reveal hidden language struggles after stroke?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- A tablet test aims to catch hidden attention and memory problems after stroke
- Can a gentle ear zap supercharge stroke rehab at home?
- Can exercise boost reading recovery in stroke survivors?